pharma · Malaria · Pharmacokinetics · CNSP
CNS Pharmaceuticals
CNS Pharmaceuticals is a pharma organization headquartered in Houston, USA. It trades on NYSE under ticker CNSP. Primary therapeutic focus areas include Malaria, Pharmacokinetics, Ovarian Cancer, Glioblastoma multiforme
Houston, TX 77027, US HQ
2017 Founded
12 Employees
Public company Type
CNSP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Houston, TX 77027, US
- Founded
- 2017
- Employees
- 12
- Programs
- 21
- Drugs
- 18
- Patents
- 0
CTX-4430
Phase 2 · small molecule · Acne Vulgaris
CTX-4430 for Acne Vulgaris is a Phase 2 program (small_molecule) at CNS Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code CTX-4430-AV-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- CNS Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Acne Vulgaris
- Status
- completed
- Trials
- 1